logo

VKTX Stock: Exploring Viking Therapeutics Inc’s Growth

Viking Therapeutics Inc experienced a somewhat steady performance in the stock market. The company’s stock reached a 1-year high of $99.41 on 02/28/24, while the lowest price for the same period was registered at $8.28 on 10/26/23.

52-week price history of VKTX Stock

A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Viking Therapeutics Inc’s current trading price is -18.69% away from its 52-week high, while its distance from the 52-week low is 876.21%. The stock’s price range during this period has spanned from $8.28 to $99.41. In the Healthcare sector, the Viking Therapeutics Inc’s shares surpassed a trading volume of approximately 19.45 million for the day, which was noticeably higher compared to the average daily volume of 9.6.11 million over the past three months.

Market Capitalization and Financial Performance: An In-Depth Look

Viking Therapeutics Inc (VKTX) has experienced a quarterly rise of 325.42% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 8.84B and boasts a workforce of 27 employees.

Making Sense of Trading Volume and Moving Average Data

Based on Barchart.com data, the company’s moving average over the 100-day period was 31.40, with a change in price of +71.02. Similarly, Viking Therapeutics Inc recorded 4,957,048 in trading volume during the last 100 days, posting a change of +723.96%.

Examining VKTX’s Debt-to-Equity Ratio: What You Need to Know

The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for VKTX stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.

VKTX Stock Stochastic Average

Today, Viking Therapeutics Inc’s raw stochastic average for the past 50 days stands at 76.52%, indicating a rise from the raw stochastic average of the last 20 days, which was 52.49%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 44.45% and 48.10% respectively.

VKTX Stock Price Performance Analysis

The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. This year’s metric has recorded a Price increase of 334.34%. However, over the past six months, we’ve seen a weaker performance of 592.93%. The price of VKTX fallen by 110.06% over the last 30 days. And in the last five days, it has surged by 24.01%.